Trial intelligence / Profile preview

Nebulized heparin for intubated ICU patients with pneumonia

IRCT20200821048470N1Phase 2Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Oct 2020
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised trial in pneumonia comparing Nebulized heparin with Placebo nebulization (2 arms). Primary endpoints: Degree of endotracheal tube obstruction, Hypoxia and 1 more. Started Oct 2020; status: completed.

02

Drugs

heparin
03

Conditions

pneumonia

Beyond the preview

Go deeper on IRCT20200821048470N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200821048470N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call